Compare MasTec Inc (MTZ) vs TransMedics Group Inc (TMDX) Price & Performance

MasTec IncTrade

TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

MasTec Inc vs TransMedics Group Inc — how do they compare? MasTec Inc trades at $350.55 (market cap $26.60B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: MasTec Inc is far larger — about 10.5× TransMedics Group Inc's market cap, and MasTec Inc is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.

	MTZ	TMDX
Market Cap	$26.60B	$2.54B
Sector	Technology	Technology
52-Week High	$437.51	$150.42
52-Week Low	$172.51	$61.99
Enterprise Value	$29.34B	$2.94B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MTZ

View details →

TMDX

TransMedics to report Q2 2026 financial results on August 4 with a live conference call.PRNewsWire · 6 hours agoNeutral Atlas Healthcare Fund's 2020 Eli Lilly bet soared 246%, showcasing early clinical insight in healthcare investing.Vst Capital · 4 days agoBullish View details →

About MasTec Inc

MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.